Precision Oncology Targets in Biliary Tract Cancer

SIMPLE SUMMARY: Biliary tract cancer is rare in the US but remains a highly lethal cancer. While the standard of care in the first-line, metastatic setting is well-established, no second-line regimen has been clearly defined as the gold standard. Many novel biomarker-targeted therapies have emerged...

Descripción completa

Detalles Bibliográficos
Autores principales: Farha, Nicole, Dima, Danai, Ullah, Fauzia, Kamath, Suneel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093316/
https://www.ncbi.nlm.nih.gov/pubmed/37046766
http://dx.doi.org/10.3390/cancers15072105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093316/
https://www.ncbi.nlm.nih.gov/pubmed/37046766
http://dx.doi.org/10.3390/cancers15072105

Ejemplares similares